Nitrazepam (Mogadon - Roche) is announced as the ‘successor to the hypnotics’: it is a new substance, chemically related to the ‘successors to the tranquillisers’ chlordiazepoxide (Librium - Roche) and diazepam (Valium - Roche). Mandrax (Roussel) is not a new substance, but a combination of two old ones: methaqualone 250 mg (marketed in 150 mg tablets as Melsedin - Boots) and diphenhydramine 25 mg (Benadryl - PD). Though their indications are the same (insomnia - ‘especially’, for Mogadon, in ‘middle-aged or elderly patients’) and warnings about unwanted effects similar (avoid alcohol with both; severe liver disease (Mandrax); pregnancy (Mogadon), they present different problems of pharmacological evaluation.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.